AMARIN CORP PLC\UK Inventory, Work in Process, Gross
AMARIN CORP PLC\UK (AMRN) had Inventory, Work in Process, Gross of $8.37 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-07-29
- 2026-06-30: Inventory, Work in Process, Gross $8.37M.
- 2026-03-31: Inventory, Work in Process, Gross $11.33M.
- 2025-12-31: Inventory, Work in Process, Gross $8.20M.
- 2025-09-30: Inventory, Work in Process, Gross $9.21M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2026-06-30 | $8.37M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $11.33M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $8.20M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $9.21M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $22.37M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $29.51M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $30.48M 10-K · filed 2026-03-02 |
| 2024-09-30 | $32.09M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $33.67M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $20.52M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $5.37M 10-K · filed 2025-03-12 |
| 2023-09-30 | $395.00K 10-Q · filed 2023-11-01 |
| 2023-06-30 | $394.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $7.08M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $52.30M 10-K · filed 2024-02-29 |
| 2022-09-30 | $59.02M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $63.03M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $56.22M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $41.97M 10-K · filed 2023-03-01 |
| 2021-09-30 | $39.52M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $48.53M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $36.09M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $30.39M 10-K · filed 2022-03-01 |
| 2020-09-30 | $23.39M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $30.06M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $22.01M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $12.03M 10-K · filed 2021-02-25 |
| 2019-09-30 | $11.91M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $3.85M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $8.65M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $8.59M 10-K · filed 2020-02-25 |
| 2018-09-30 | $11.60M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $10.81M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $13.47M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $10.84M 10-K · filed 2019-02-27 |
| 2012-12-31 | $15.47M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |